View Author
screening cancer colonoscopy colorectal model colorectal cancer strategy study adenomas population stage colorectal cancer screening sensitivity incidence analysis mortality adenoma treatment result health table death surveillance trial individual interval cost-effectiveness estimate patient number colonoscopy screening women sigmoidoscopy factor group colon crc screening trend disease history difference state ct colonography diagnosis colonoscopie 5 years colonography endoscopy occult blood crc mortality life-year van ballegooijen m guideline ctc screening crc incidence assumption value phase parameter risk factors 10 years detection level miscan duration lifeyear prevalence occult blood test adherence intervention polyps effect referral figure program chapter screening strategies microsimulation fl exible sigmoidoscopy
10 Most Recent Publications
|
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
(Article)
Goede, S.L. Roon, A.H.C. van Reijerink, J.C.I.Y. Vuuren, A.J. van Lansdorp-Vogelaar, I. Habbema, J.D.F. Kuipers, E.J. Leerdam, M.E. van Ballegooijen, M. van |
2013-05-01
|
|
Fecal occult blood testing when colonoscopy capacity is limited
(Article)
Wilschut, J.A. Habbema, J.D.F. Leerdam, M.E. van Hol, L. Lansdorp-Vogelaar, I. Kuipers, E.J. Ballegooijen, M. van |
2011-12-07
|
|
Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
(Article)
Brenner, H. Altenhofen, L. Katalinic, A. Lansdorp-Vogelaar, I. Hoffmeister, M. |
2011-11-15
|
|
Comparative economic evaluation of data from the ACRIN national CT colonography trial with three cancer intervention and surveillance modeling network microsimulations
(Article)
Vanness, D.J. Knudsen, A.B. Chen, M.-H. Johnson, C.D. Lansdorp-Vogelaar, I. Rutter, C.M. Gareen, I.F. Herman, B.A. Kuntz, K.M. Zauber, A.G. Ballegooijen, M. van Feuer, E.J. |
2011-11-01
|
|
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
(Article)
Wilschut, J.A. Hol, L. Dekker, E. Jansen, J.B. Leerdam, M.E. van Lansdorp-Vogelaar, I. Kuipers, E.J. Habbema, J.D.F. Ballegooijen, M. van |
2011-11-01
|
|
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
(Article)
Wilschut, J.A. Steyerberg, E.W. Leerdam, M.E. van Lansdorp-Vogelaar, I. Habbema, J.D.F. Ballegooijen, M. van |
2011-09-15
|
|
Productivity savings from colorectal cancer prevention and control strategies
(Article)
Bradley, C.J. Lansdorp-Vogelaar, I. Yabroff, K.R. Dahman, B. Mariotto, A. Feuer, E.J. Brown, M.L. |
2011-08-01
|
|
State disparities in colorectal cancer mortality patterns in the United States
(Article)
Naishadham, D. Lansdorp-Vogelaar, I. Siegel, R. Cokkinides, V. Jemal, A. |
2011-07-01
|
|
Cost-effectiveness of colorectal cancer screening
(Article)
Lansdorp-Vogelaar, I. Knudsen, A.B. Brenner, H. |
2011-07-01
|
|
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
(Article)
Kuntz, K.M. Lansdorp-Vogelaar, I. Rutter, C.M. Knudsen, A.B. Ballegooijen, M. van Savarino, J.E. Feuer, E.J. Zauber, A.G. |
2011-07-01
|
